European Journal of Radiology
Volume 45, Issue 1 , Pages 8-17 , January 2003

Classification, staging and prognosis of lung cancer

Received 17 September 2002 ,Revised 18 September 2002 ,Accepted 19 September 2002.

References 

  1. American Thoracic Society/European Respiratory Society . Pretreatment evaluation of non-small cell lung cancer. Am. J. Respir. Crit. Care Med. 1997;156:320–332
  2. Travis WD, Lubin J, Ries L, Devesa S. United States lung carcinoma incidence trends—declining for most histological types among males, increasing among females. Cancer. 1996;77(12):2464–2470
  3. Beckett WS. Epidemiology and etiology of lung cancer. Clin. Chest Med. 1993;14(1):1–15
  4. Bartecchi CE, MacKenzie TD, Schrier RW. The human cost of tobacco use (2). N. Engl. J. Med. 1994;330(14):975–980
  5. McDonald JC, Liddell FD, Dufresne A, McDonald AD. The 1891–1920 birth cohort of Quebec chrysatile miners and millers: mortality 1976–88. Br. J. Ind. Med. 1993;50(12):1073–1081
  6. Pershagen G. The carcinogenicity of arsenic. Environ. Health Perspect. 1981;40:93–100
  7. Chovil A, Sutherland RB, Halliday M. Respiratory cancer in a cohort of nickel sinter plant workers. Br. J. Ind. Med. 1981;38(4):327–333
  8. Sevc J, Tomasek L, Kunk E, Placek V, Chmelevsky D, Barclay D, et al.  A survey of the Czechoslovak follow-up of lung cancer mortality in uranium miners. Health Phys. 1993;64(4):355–369
  9. Oliphant L, McFadden RG. Lung cancer following radiotherapy for Hodgkin's disease. Can. Med. Assoc. J. 1985;132(5):533–535
  10. Hubbard R, Venn A, Lewis S, Britton J. Lung cancer and cryptogenic fibrosing alveolitis. Am. J. Respir. Crit. Care Med. 2000;161(1):5–8
  11. Marchesani W. Ueber den primaeren bronchieikrebs. Frankfurter Pathol. 1924;30:158
  12. Armstrong P. Neoplasms of the lungs, airways and pleura. In:  Armstrong P,  Wilson AG,  Dee P,  Hansell DM editor. Imaging of diseases of the chest. 3rd ed. London: Mosby (Harcourt); 2000;p. 305–401
  13. Chaudhuri MR. Primary pulmonary cavitating carcinomas. Thorax. 1973;28:354–366
  14. Woodring JH, Stelling CB. Adenocarcinoma of the lung: a tumour with changing pleomorphic character. Am. J. Roentgenol. 1983;140:657–664
  15. Aoki T, Nakata H, Watanabe H, Nakamura K, Kasai T, Hasimoto H, et al.  Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumour doubling times. Am. J. Roentgenol. 2000;174:763–768
  16. Bonomo L, Storto ML, Ciccotosto C, Polverosi R, Merlino B, Bellelli M, et al.  Bronchoalveolar carcinoma of the lung. Eur. Radiol. 1998;8:996–1001
  17. Clarke LR, Stull MA, Twigg HL. Chest case of the day. Bronchoalveolar carcinoma of the lung. Am. J. Roentgenol. 1990;154:1318–1319
  18. Zwirewich CV, Vedal S, Miller RR, Muller NL. Solitary pulmonary nodule: high resolution CT and radiologic-pathologic correlation. Radiology. 1991;179:469–476
  19. Kazerooni EA, Bhalla M, Shepard JA, McLoud TC. Adenosquamous carcinoma of the lung: radiologic appearance. Am. J. Roentgenol. 1994;163:301–306
  20. Pearlberg JL, Sandler MA, Lewis JW, Beute GH, Alpern MB. Small-cell bronchogenic carcinoma: CT evaluation. Am. J. Roentgenol. 1988;150:265–268
  21. Fraser RG, Pare JAP. In: Diagnosis of diseases of the chest. 4th ed. Philadelphia: WB Saunders; 1999;p. 1142–1143
  22. Shin MS, Jackson LK, Shelton RW, Greene RE. Giant cell carcinoma of the lung. Clin. Chest. 1986;89:366–369
  23. Denoix PF. Enquete permanent dans les centres anticancereux. Bull. Inst. Nat. Hyg. 1946;1:70
  24. American Joint Committee on Cancer (AJCC) . Lung. In:  Beahrs OH,  Henson DE,  Hutter RVP editor. Manual for staging of cancer. 4th ed. Philadelphia: JB Lippincott; 1992;p. 120
  25. International Union Against Cancer (UICC) . Lung tumours (ICDO-162). In:  Sobin LH,  Wittekind CH editor. TNM Classification of malignant tumours. 5th ed. New York: Wiley-Liss; 1997;
  26. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest. 1997;111:1718–1723
  27. van Rens MT, Zanen P, de La Riviere B. Survival in synchronous versus single lung cancer: upstaging better reflects prognosis. Chest. 2000;118:952–958
  28. Mountain CF, Libshitz HI, Hermes KE. In: Lung cancer. A handbook for staging, imaging and lymph node classification. Houston: Mountain and Libshitz; 1999;p. 65
  29. Mountain CF. Revisions in the International system for staging lung cancer. Chest. 1997;111:1710–1717
  30. Abrams J, Doyle LA, Aisner J. Staging, prognostic factors and special considerations in small cell lung cancer. Semin. Oncol. 1988;15(3):261–277
  31. Mulshine JL, Makuich RW, Johnston-Early A, Mathews MJ, Carney DN, Ihde DC, et al.  Diagnosis and significance of liver metastases in small cell carcinoma of the lung. J. Clin. Oncol. 1984;2(7):733–741
  32. Hirsch FR, Hansen HH. Bone marrow involvement in small cell anaplastic carcinoma of the lung: prognostic and therapeutic aspects. Cancer. 1980;46(1):206–211
  33. Kochhar R, Frytak S, Shaw EG. Survival of patients with extensive small cell lung cancer who have only brain metastases at initial diagnosis. Am. J. Clin. Oncol. 1997;20(2):125–127
  34. Richards MA, Stockton D, Babb P, Coleman MP. How many deaths have been avoided through improvements in cancer survival?. Br. Med. J. 2000;320:895–898
  35. Fraser RS, Muller NL, Colman N, Pare PD. Diagnosis of diseases of the chest, 4th ed., vol. 2. WB Saunders, 1999: 1197.
  36. Ishida T, Kaneko S, Yokoyama H, Inoue T, Sugio K, Sugimachi K. Adenosquamous carcinoma of the lung: clinico-pathologic and immunohistochemical features. Am. J. Clin. Pathol. 1992;97(5):678–685
  37. Blanke CD, Johnson DH. Treatment of small cell lung cancer. Semin. Thorac. Cardiovasc. Surg. 1997;9(1):101–110
  38. Feinstein AR, Wells CK. A clinical severity staging system for patients with lung cancer. Medicine. 1990;69(1):1–33
  39. Glaser HS, Kaiser LR, Anderson DJ, Molina PL, Emami B, Roper CL, et al.  Indeterminate mediastinal invasion in bronchogenic carcinoma: CT evaluation. Radiology. 1989;173:38–42
  40. Quint LE, Francis IR. Radiologic staging of lung cancer. J. Thorac. Imaging. 1999;14:235–246
  41. Aitken K, Armstrong P. Cinical imaging for staging lung cancer. Imaging. 1992;4:15–22
  42. Webb WR, Jensen BG, Sollitto R, de Geer G, McCowin M, Gamsu G, et al.  Bronchogenic carcinoma staging with MR compared with staging with CT and surgery. Radiology. 1985;156:117–124
  43. Grenier P, Dubray B, Carette MF. Preoperative thoracic staging of lung cancer: CT and MR evaluation. Diagn. Interventional Radiol. 1989;1:23
  44. McLoud TC, Bourgouin PM, Greenberg RW, Kosiuk JP, Templeton PA, Shepard JA, et al.  Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology. 1992;182:319–323
  45. Primak SL, Lee KS, Logan PM, Miller RR, Muller NL. Bronchogenic carcinoma: utility of CT in the evaluation of patients with suspected lesions. Radiology. 1994;193(3):795–800
  46. Webb WR, Gatsonis C, Zerhouni EA, Heelan RT, Glazer GM, Francis IR, et al.  CT and MR imaging in non-small cell bronchogenic carcinoma. Report of Radiologic Diagnostic Oncology Group. Radiology. 1991;178(3):705–713
  47. DeLeyn P, Schoonooghe P, Defeffe G. Surgery for non-small cell lung cancer with unsuspected metastasis to ipsilateral mediastinum or subcarinal lymph nodes (N2 disease). Eur. J. Cardiothorac. Surg. 1996;10:649–654
  48. Steinert HC, Hauser M, Alleman F, Engel H, Berthold T, von Schultthess GK, et al.  Non-small cell lung cancer: nodal staging with FDG PET vs CT with correlative lymph node mapping and sampling. Radiology. 1997;202:441–446
  49. Vansteenkiste JF, Stroobants SG, De Leyn PR, Dupont PJ, Verschakelen JA, Nackaerts KL, et al.  Mediastinal lymph node staging with FDG PET scan in patients with potentially operable non-small cell lung cancer; a prospective analysis of 50 cases. Leuven Lung Cancer Group. Chest. 1997;112:1480–1486
  50. Guhlmann A, Storck M, Kotzerke J, Moog F, Sunder-Plassmann L, Reske SN. Lymph node staging in non-small cell lung cancer; evaluation by [18F] FDG positron emission tomography (PET). Thorax. 1997;52:438–441
  51. Dwamena BA, Sonnad SS, Ango bald JO, Wahl RL. Metastases from non-small cell lung cancer; mediastinal staging in the 1990's—meta-analytic comparison of PET and CT. Radiology. 1999;213:530–536
  52. Pieterman RM, van Putten JW, Meuzelaar JJ. Preoperative staging of non-small cell lung carcinoma with positron emission tomography. N. Engl. J. Med. 2000;343:290–292
  53. Valk PE, Pounds TR, Hopkins DM, Haseman MK, Hofer GA, Greiss HB, et al.  Staging non-small cell lung cancers by whole-body positron emission tomographic imaging. Ann. Thorac. Surg. 1995;60:1573–1581
  54. Mountain CF. Surgical treatment of lung cancer. Crit. Rev. Oncol. Hematol. 1991;11:179–207
  55. Lewis P, Griffin S, Marsden P, Gee T, Nunan T, Malsey M, et al.  Whole body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer. Lancet. 1994;344(8932):1265–1266
  56. Weder W, Schmid RA, Bruchhaus H, Hillinger S, von Schulthess GK, Steinert HC. Detection of extrathoracic metastases by positron emission tomography in lung cancer. Ann. Thorac. Surg. 1998;66:886–892

PII: S0720-048X(02)00287-5

European Journal of Radiology
Volume 45, Issue 1 , Pages 8-17 , January 2003

Article Tools

* Image Usage & Resolution